1. Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries

   • Brahim Gaies

   Original Paper 08 February 2022 Pages: 1415 - 1436

   

2. Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries

   • Rudy Douven
   • Lukas Kauer
   • Xiaoxi Zhao

   Original Paper Open access 07 February 2022 Pages: 1437 - 1453

   

3. Determinants of willingness to pay for health services: a systematic review of contingent valuation studies

   • Caroline Steigenberger
   • Magdalena Flatscher-Thoeni
   • Andrea M. Leiter

   Original Paper 15 February 2022 Pages: 1455 - 1482

   

4. Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics

   • Axel C. Mühlbacher
   • Andrew Sadler
   • Yvonne Jordan

   Original Paper Open access 09 February 2022 Pages: 1483 - 1496

   

5. Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements

   • Eduardo Costa
   • Carolina Santos

   Original Paper 22 February 2022 Pages: 1497 - 1518

   

6. Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014

   • Laura Hirello
   • Mohammad Habibullah Pulok
   • Mohammad Hajizadeh

   Original Paper 19 February 2022 Pages: 1519 - 1533

   

7. The effect of informal caregiving on medication: evidence from administrative data

   • Magdalena Stroka-Wetsch

   Original Paper Open access 27 June 2022 Pages: 1535 - 1545

8. The attractiveness of jobs in the German care sector: results of a factorial survey

   • Martin Kroczek
   • Jochen Späth

   Original Paper Open access 18 March 2022 Pages: 1547 - 1562

9. Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database

   • Zuzana Špacírová
   • David Epstein
   • Jaime Espín

   Original Paper 26 February 2022 Pages: 1563 - 1575

10. A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots

    • Elahe Khorasani
    • Majid Davari
    • Vida Varahrami

    Original Paper 02 March 2022 Pages: 1577 - 1590

    

11. The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design

    • Simona Gamba
    • Niklas Jakobsson
    • Mikael Svensson

    Original Paper Open access 25 February 2022 Pages: 1591 - 1599

    

12. Looking into the black box of “Medical Innovation”: rising health expenditures by illness type

    • Friedrich Breyer
    • Normann Lorenz
    • Thomas Schober

    Original Paper Open access 17 March 2022 Pages: 1601 - 1612

    

13. Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology

    • Stefan A. Lipman
    • Liying Zhang
    • Arthur E. Attema

    Correction Open access 05 October 2022 Pages: 1613 - 1615